Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis

• Michael V. Chiorean,
• Jessica R. Allegretti,
• Puza P. Sharma,
• Benjamin Chastek,
• Leonardo Salese,
• Elizabeth J. Bell,
• Jesse Peterson-Brandt,
• Joseph C. Cappelleri,
• Xiang Guo,
• Nabeel Khan

Affiliations

Michael V. Chiorean

Swedish Medical Center

Jessica R. Allegretti

Brigham and Women’s Hospital

Puza P. Sharma

Pfizer Inc

Benjamin Chastek

Optum Life Sciences, HEOR

Leonardo Salese

Pfizer Inc

Elizabeth J. Bell

Optum Life Sciences, HEOR

Jesse Peterson-Brandt

Optum Life Sciences, HEOR

Joseph C. Cappelleri

Pfizer Inc

Xiang Guo

Pfizer Inc

Nabeel Khan

Perelman School of Medicine, University of Pennsylvania